Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection

IMPORTANCE: Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of morbidity and mortality for patients with type 2 diabetes (T2D) and chronic kidney disease (CKD). However, testing for albuminuria among patients with T2D is substantially underutilized in clinical practice; many...

Descripción completa

Detalles Bibliográficos
Autores principales: Michos, Erin D., Bakris, George L., Rodbard, Helena W., Tuttle, Katherine R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
State-of-the-Art Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258236/
https://www.ncbi.nlm.nih.gov/pubmed/37313358
http://dx.doi.org/10.1016/j.ajpc.2023.100502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258236/
https://www.ncbi.nlm.nih.gov/pubmed/37313358
http://dx.doi.org/10.1016/j.ajpc.2023.100502

Ejemplares similares